Mitsubishi UFJ Kokusai Asset Management Co. Ltd. Has $3.39 Million Holdings in Agilent Technologies Inc (A)

Mitsubishi UFJ Kokusai Asset Management Co. Ltd. raised its holdings in shares of Agilent Technologies Inc (NYSE:A) by 1.6% during the fourth quarter, HoldingsChannel.com reports. The fund owned 48,835 shares of the medical research company’s stock after purchasing an additional 771 shares during the quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd.’s holdings in Agilent Technologies were worth $3,385,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also modified their holdings of A. TimesSquare Capital Management LLC bought a new stake in Agilent Technologies during the 3rd quarter valued at $58,550,000. Janus Henderson Group PLC raised its holdings in Agilent Technologies by 2,135.0% during the 2nd quarter. Janus Henderson Group PLC now owns 836,051 shares of the medical research company’s stock valued at $49,587,000 after acquiring an additional 798,643 shares during the period. Bank of Montreal Can increased its holdings in shares of Agilent Technologies by 187.3% in the fourth quarter. Bank of Montreal Can now owns 742,001 shares of the medical research company’s stock worth $49,693,000 after purchasing an additional 483,721 shares during the period. Wells Fargo & Company MN increased its holdings in shares of Agilent Technologies by 27.6% in the third quarter. Wells Fargo & Company MN now owns 2,184,502 shares of the medical research company’s stock worth $140,244,000 after purchasing an additional 473,047 shares during the period. Finally, Koch Industries Inc. bought a new position in shares of Agilent Technologies in the second quarter worth $438,000.

Agilent Technologies Inc (NYSE A) opened at $66.98 on Friday. The company has a market capitalization of $21,012.32, a price-to-earnings ratio of 31.90, a P/E/G ratio of 1.96 and a beta of 1.28. The company has a debt-to-equity ratio of 0.37, a current ratio of 3.30 and a quick ratio of 2.85. Agilent Technologies Inc has a 12 month low of $50.00 and a 12 month high of $75.00.

Agilent Technologies (NYSE:A) last released its earnings results on Monday, November 20th. The medical research company reported $0.67 EPS for the quarter, beating the Zacks’ consensus estimate of $0.62 by $0.05. The business had revenue of $1.19 billion for the quarter, compared to analysts’ expectations of $1.17 billion. Agilent Technologies had a return on equity of 16.95% and a net margin of 15.30%. The firm’s revenue was up 7.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.59 earnings per share. equities analysts forecast that Agilent Technologies Inc will post 2.58 EPS for the current year.

The company also recently announced a quarterly dividend, which was paid on Wednesday, January 24th. Investors of record on Tuesday, January 2nd were paid a $0.149 dividend. This represents a $0.60 dividend on an annualized basis and a yield of 0.89%. The ex-dividend date of this dividend was Friday, December 29th. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.13. Agilent Technologies’s dividend payout ratio is currently 28.57%.

In other Agilent Technologies news, SVP Jacob Thaysen sold 22,583 shares of the company’s stock in a transaction dated Tuesday, November 28th. The shares were sold at an average price of $70.41, for a total transaction of $1,590,069.03. Following the completion of the sale, the senior vice president now directly owns 63,042 shares in the company, valued at $4,438,787.22. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Michael R. Mcmullen sold 21,850 shares of the company’s stock in a transaction dated Monday, January 29th. The shares were sold at an average price of $75.00, for a total transaction of $1,638,750.00. Following the sale, the chief executive officer now owns 324,687 shares of the company’s stock, valued at $24,351,525. The disclosure for this sale can be found here. In the last three months, insiders sold 219,991 shares of company stock worth $15,468,795.

Several research analysts have recently weighed in on A shares. Zacks Investment Research raised shares of Agilent Technologies from a “hold” rating to a “buy” rating and set a $76.00 price target on the stock in a report on Tuesday, October 31st. Barclays reaffirmed a “buy” rating and issued a $74.00 price target on shares of Agilent Technologies in a report on Monday, January 8th. Robert W. Baird reaffirmed a “buy” rating and issued a $70.00 price target on shares of Agilent Technologies in a report on Friday, October 20th. Evercore ISI started coverage on shares of Agilent Technologies in a report on Wednesday, January 3rd. They issued an “outperform” rating and a $75.00 price target on the stock. Finally, ValuEngine cut shares of Agilent Technologies from a “buy” rating to a “hold” rating in a report on Friday, December 1st. Six investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $69.25.

ILLEGAL ACTIVITY WARNING: “Mitsubishi UFJ Kokusai Asset Management Co. Ltd. Has $3.39 Million Holdings in Agilent Technologies Inc (A)” was reported by Community Financial News and is owned by of Community Financial News. If you are viewing this report on another domain, it was illegally stolen and republished in violation of US & international trademark & copyright laws. The legal version of this report can be accessed at https://www.com-unik.info/2018/02/10/mitsubishi-ufj-kokusai-asset-management-co-ltd-has-3-39-million-holdings-in-agilent-technologies-inc-a.html.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit